MicroRNA‐146a and Human Disease
暂无分享,去创建一个
Xi-sha Chen | Yinglan Li | L. Li | X-P Chen | Y-J Li | L. Li | X.‐P. Chen | Y.‐J. Li | Liucun Li | X. Chen
[1] Hao Wu,et al. Distinct molecular mechanism for initiating TRAF6 signalling , 2002, Nature.
[2] Isaac S. Kohane,et al. Distinctive patterns of microRNA expression in primary muscular disorders , 2007, Proceedings of the National Academy of Sciences.
[3] Jian-Rong Yang,et al. A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma. , 2008, Carcinogenesis.
[4] J. Inoue,et al. NF-kappaB activation in development and progression of cancer. , 2007, Cancer science.
[5] C. Croce,et al. The role of microRNA genes in papillary thyroid carcinoma. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[6] P. Tam. Faculty Opinions recommendation of miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. , 2009 .
[7] Zhaohui Huang,et al. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer , 2010, International journal of cancer.
[8] Y. Duan,et al. Cyclic stretch induced miR-146a upregulation delays C2C12 myogenic differentiation through inhibition of Numb. , 2009, Biochemical and biophysical research communications.
[9] Kaleb M. Pauley,et al. Contrast in aberrant microRNA expression in systemic lupus erythematosus and rheumatoid arthritis: is microRNA-146 all we need? , 2009, Arthritis and rheumatism.
[10] C. Birchmeier,et al. Notch Function in Myogenesis , 2007, Cell cycle.
[11] Chaoqian Xu,et al. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2 , 2011, Nature Medicine.
[12] D. Banerjee,et al. MiRSNPs or MiR-polymorphisms, new players in microRNA mediated regulation of the cell: Introducing microRNA pharmacogenomics , 2008, Cell cycle.
[13] C. Croce,et al. MicroRNA-133 controls cardiac hypertrophy , 2007, Nature Medicine.
[14] Jaekyu Shin,et al. Pharmacogenetics: from discovery to patient care. , 2009, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[15] A. Kasprzyk,et al. Narrowing and genomic annotation of the commonly deleted region of the 5q- syndrome. , 2002, Blood.
[16] Hua Zhao,et al. A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. , 2008, Carcinogenesis.
[17] D. Banerjee,et al. A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance , 2007, Proceedings of the National Academy of Sciences.
[18] Pin Wang,et al. MicroRNA-146a Feedback Inhibits RIG-I-Dependent Type I IFN Production in Macrophages by Targeting TRAF6, IRAK1, and IRAK21 , 2009, The Journal of Immunology.
[19] Kedar S Vaidya,et al. Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. , 2009, Cancer research.
[20] J. Bertino,et al. MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine. , 2009, Pharmacogenomics.
[21] M. Lindsay,et al. Rapid Changes in MicroRNA-146a Expression Negatively Regulate the IL-1β-Induced Inflammatory Response in Human Lung Alveolar Epithelial Cells1 , 2008, The Journal of Immunology.
[22] Ryan D. Morin,et al. Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotype , 2010, Nature Medicine.
[23] A. Whitehead,et al. IL-1 Signaling Cascade in Liver Cells and the Involvement of a Soluble Form of the IL-1 Receptor Accessory Protein1 2 , 2000, The Journal of Immunology.
[24] X. Chen,et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases , 2008, Cell Research.
[25] O. Hermine,et al. Deregulation of microRNA involved in hematopoiesis and the immune response in HTLV-I adult T-cell leukemia. , 2009, Blood.
[26] P. Tak,et al. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. , 2009, Arthritis and rheumatism.
[27] S. Fedele,et al. MicroRNAs and ischemic heart disease: towards a better comprehension of pathogenesis, new diagnostic tools and new therapeutic targets. , 2009, Recent patents on cardiovascular drug discovery.
[28] Liang-Hu Qu,et al. MicroRNA Patterns Associated with Clinical Prognostic Parameters and CNS Relapse Prediction in Pediatric Acute Leukemia , 2009, PloS one.
[29] J. Inoue,et al. NF‐κB activation in development and progression of cancer , 2007 .
[30] D. Baltimore,et al. NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses , 2006, Proceedings of the National Academy of Sciences.
[31] Ulus Atasoy,et al. Circulating microRNAs in breast cancer and healthy subjects , 2009, BMC Research Notes.
[32] V. Ambros. The functions of animal microRNAs , 2004, Nature.
[33] M. Lindsay,et al. microRNAs and the immune response. , 2008, Trends in immunology.
[34] J. Mrázek,et al. Epstein-Barr Virus-Encoded Latent Membrane Protein 1 (LMP1) Induces the Expression of the Cellular MicroRNA miR-146a , 2007, RNA biology.
[35] Shizuo Akira,et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses , 2004, Nature Immunology.
[36] Keiichiro Nishida,et al. Expression of microRNA-146 in rheumatoid arthritis synovial tissue. , 2008, Arthritis and rheumatism.
[37] Michael Detmar,et al. Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. , 2008, Arthritis and rheumatism.
[38] M. Lindsay,et al. Role of miRNA-146a in the regulation of the innate immune response and cancer. , 2008, Biochemical Society transactions.
[39] Kaleb M. Pauley,et al. miR-146a Is Critical for Endotoxin-induced Tolerance , 2009, The Journal of Biological Chemistry.
[40] N. S. Asli,et al. MicroRNAs in organogenesis and disease. , 2008, Current molecular medicine.
[41] Stefano Volinia,et al. Interferon modulation of cellular microRNAs as an antiviral mechanism , 2007, Nature.
[42] S. Schokrpur,et al. Expression of microRNA-146 suppresses NF-κB activity with reduction of metastatic potential in breast cancer cells , 2008, Oncogene.
[43] Zhen Lin,et al. Epstein-Barr Virus Latent Membrane Protein 1 Induces Cellular MicroRNA miR-146a, a Modulator of Lymphocyte Signaling Pathways , 2007, Journal of Virology.
[44] Walter J. Lukiw,et al. An NF-κB-sensitive Micro RNA-146a-mediated Inflammatory Circuit in Alzheimer Disease and in Stressed Human Brain Cells* , 2008, Journal of Biological Chemistry.
[45] Wei Zhang,et al. A functional polymorphism in Pre‐miR‐146a gene is associated with prostate cancer risk and mature miR‐146a expression in vivo , 2010, The Prostate.
[46] Osamu Takeuchi,et al. MDA5/RIG-I and virus recognition. , 2008, Current opinion in immunology.
[47] A. Pivarcsi,et al. MicroRNAs: novel regulators in skin inflammation , 2008, Clinical and experimental dermatology.
[48] T. Rando,et al. The regulation of Notch signaling in muscle stem cell activation and postnatal myogenesis. , 2005, Seminars in cell & developmental biology.
[49] L. Young,et al. Epstein–Barr virus and oncogenesis: from latent genes to tumours , 2003, Oncogene.
[50] Haifan Lin,et al. MicroRNAs: key regulators of stem cells , 2009, Nature Reviews Molecular Cell Biology.
[51] Kaleb M. Pauley,et al. Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients , 2008, Arthritis research & therapy.
[52] Barbara Jarzab,et al. Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma , 2008, Proceedings of the National Academy of Sciences.
[53] O. Crasta,et al. Suppression of LPS-induced Interferon-gamma and nitric oxide in splenic lymphocytes by select estrogen-regulated microRNAs: a novel mechanism of immune modulation. , 2008, Blood.
[54] N. Rajewsky,et al. A pancreatic islet-specific microRNA regulates insulin secretion , 2004, Nature.